<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <div xmlns="" tagxxx="article">
      <head>
         <meta content="Frontiers Media S.A." name="citation_publisher"></meta>
         <meta content="10.3389/fgene.2013.00240" name="citation_doi"></meta>
         <meta content="Practice variation across consent templates for biobank research. a survey of German biobanks" name="citation_title"></meta>
         <title>Practice variation across consent templates for biobank research. a survey of German
            biobanks
         </title>
         <div tagxxx="contrib-group">
            <meta content="Irene Hirschberg" name="citation_author"></meta>
            <meta content="" name="citation_author_institution_ref"></meta>
            <meta content="Hannes Knüppel" name="citation_author"></meta>
            <meta content="" name="citation_author_institution_ref"></meta>
            <meta content="Daniel Strech" name="citation_author"></meta>
            <meta content="*" name="citation_author_institution_ref"></meta>
         </div>
         <meta content="" name="email"></meta>
         <meta content="" name="conflict"></meta>
         <meta content="" name="contribs"></meta>
         <meta content="2013-11-14" name="citation_pubdate"></meta>
         <meta content="Copyright 2013: " name="citation_copyright"></meta>
         <meta content="Licence This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms." name="citation_licence"></meta>
         <meta content="" name="citation_funding"></meta>
         <meta content="" name="citation_pagecount"></meta>
         <meta content="" name="citation_data"></meta>
      </head>
      <div id="abstract" tag="abstract">
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <b>Introduction: </b>Informed, voluntary, and valid consent from biomaterial donors is a precondition for
            biobank research. Valid consent protects donors’ rights and helps maintain public
            trust in biobank research. Harmonization of consent procedures in biobank research
            is needed, because of the widely shared vision on national and international networking
            of biobanks including data and sample sharing. So far, no study has assessed and compared
            the content of current consent forms especially for biobank research. The objective
            of this study was to perform a content analysis of consent forms in German biobanks.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <b>Methods: </b>Based on ten guidelines for biomedical research, we developed an assessment matrix
            with 41 content issues that are potentially relevant for consent forms in biobank
            research. This assessment matrix was applied in a thematic text analysis to 30 consent
            documents of German biobanks identified via the German Biobank Registry in July 2012.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <b>Results: </b>Coverage of the 41 items in the assessed consent forms varied widely. For example,
            the items “Right to withdraw consent (without disadvantage),” “Policy for genetic
            information/consent to genetic analyzes” and “International cooperation/transborder
            use” were addressed in 97, 40, and 23% of all 30 consent forms respectively. The number
            of items covered by a single consent form ranged from 9 to 36 (22–88% out of 41 items).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <b>Discussion: </b>Our findings serve as a starting point to reflect upon the spectrum of consent issues
            that must be addressed in biobank research. The findings show that the majority of
            consent forms for German biobanks, if not all, should be improved and harmonized to
            better support an informed and balanced choice of potential donors and to facilitate
            networking of biobanks. Best practice models for consent forms in biobank research
            should be developed and biobank operators need to be more aware of relevant consent
            issues.
         </p>
      </div>
      <div id="">
         <h2>INTRODUCTION</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Biobanks are collections of human biological samples and related health/personal information.
            A high quality biobank that organizes samples for use by biomedical researchers is
            seen as an important resource for health research, including basic research, questions
            in personalized or stratified medicine (genetic and other biomarkers), and research
            in widespread diseases (
            <span ref-type="bibr" rid="B1">Asslaber and Zatloukal, 2007</span>; 
            <span ref-type="bibr" rid="B39">Zika et al., 2010</span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The development of large-scale population-based as well as disease-specific biobanks
            also implies several new ethical, legal and social challenges. These comprise, e.g.,
            issues around the role of ethics committees, data protection, dealing with incidental
            findings, public involvement measures, and particularly regarding the need for new
            or at least modified models of informed consent of the donors (
            <span ref-type="bibr" rid="B5">Budimir et al., 2011</span>; 
            <span ref-type="bibr" rid="B19">Gottweis and Kaye, 2012</span>). As acquired for diagnostic and therapeutic procedures in clinical as well as in
            research settings, informed, voluntary, and valid consent is a precondition for the
            collection of samples and clinical data of donors in a biobank. It also tends to protect
            donors’ rights and autonomy and to maintain public trust in biobank research. Crucial
            points include the scope and content of consent forms, for example, how do consent
            forms address potential future research projects that might involve the donated biomaterials
            (broad/general vs. narrow/specific consent) (
            <span ref-type="bibr" rid="B6">Cambon-Thomsen et al., 2007</span>; 
            <span ref-type="bibr" rid="B20">Greely, 2007</span>; 
            <span ref-type="bibr" rid="B21">Hansson, 2009</span>; 
            <span ref-type="bibr" rid="B31">OECD, 2009</span>; 
            <span ref-type="bibr" rid="B5">Budimir et al., 2011</span>; 
            <span ref-type="bibr" rid="B12">Deutscher Ethikrat, 2011</span>). Additionally, biobank research consent procedures and documentation involve different
            or additional aspects compared with clinical research, e.g., concerning data protection
            and data sharing with other researchers (
            <span ref-type="bibr" rid="B24">Hoeyer et al., 2005</span>; 
            <span ref-type="bibr" rid="B3">Beskow et al., 2010</span>; 
            <span ref-type="bibr" rid="B30">McGuire and Beskow, 2010</span>; 
            <span ref-type="bibr" rid="B33">Pawlikowski et al., 2011</span>). Besides, the harmonization of consent templates, at least of the most important
            criteria, is essential for future cooperation and networking at the national and international
            level.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Though information and consent documents do certainly not substitute the discussion
            between clinician/researcher and patient/participant, they are an important component
            within the informed consent procedure and its documentation, as well as for legal
            aspects. Regarding quality and performance of consent forms in clinical or research
            contexts, several empirical studies demonstrated that consent forms are often not
            adequate in content, comprehensibility or practicability and do not meet participants’
            needs. Improvements are necessary within consent procedure and documents to support
            an adequately well-balanced and evidence-based decision-making process by participants
            (
            <span ref-type="bibr" rid="B27">Jefford and Moore, 2008</span>; 
            <span ref-type="bibr" rid="B32">Padhy et al., 2011</span>; 
            <span ref-type="bibr" rid="B4">Brehaut et al., 2012</span>; 
            <span ref-type="bibr" rid="B28">Mandava et al., 2012</span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Several sets of ethical guidance define the required criteria for consent in clinical
            research, e.g., (
            <span ref-type="bibr" rid="B8">Council for International Organizations of Medical Sciences [CIOMS], 2002</span>; 
            <span ref-type="bibr" rid="B38">World Medical Association [WMA], 2008</span>). Some guidelines also explicitly mention required criteria for consent in biobank
            research, e.g., (
            <span ref-type="bibr" rid="B31">OECD, 2009</span>). Nevertheless, there is no specific guidance for biobank research and consent procedures
            that can be employed as a tool for the assessment of consent forms’ content in clinical
            or biobank research. Furthermore, we currently lack a broadly accepted “best practice”
            model for consent forms in biobank research (
            <span ref-type="bibr" rid="B19">Gottweis and Kaye, 2012</span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Also in Germany, the number and importance of biobank facilities and projects with
            similar requirements is increasing, e.g., in population-wide studies such as KoraGEN
            and PopGEN, and the National Biobank Initiative (“Nationale Biomaterialbanken Initiative”)
            funded by the German Federal Ministry of Education and Research (Bundesministerium
            für Bildung und Forschung, BMBF).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Existing studies that describe different biobanks and their governance strategies
            also indicate challenges in consent procedures (
            <span ref-type="bibr" rid="B23">Hirtzlin et al., 2003</span>; 
            <span ref-type="bibr" rid="B39">Zika et al., 2010</span>; 
            <span ref-type="bibr" rid="B19">Gottweis and Kaye, 2012</span>). Some research groups propose a unified consent model or possible content for a
            consent form in biobank research (
            <span ref-type="bibr" rid="B34">Porteri and Borry, 2008</span>; 
            <span ref-type="bibr" rid="B35">Salvaterra et al., 2008</span>) or for whole genome sequencing studies in the clinical context (
            <span ref-type="bibr" rid="B2">Ayuso et al., 2013</span>). Besides, there are studies comparing participant information and consent forms
            in genetic research (
            <span ref-type="bibr" rid="B29">Mascalzoni et al., 2010</span>) or in clinical trials (
            <span ref-type="bibr" rid="B25">Hüppe et al., 2013</span>). But so far, no study has assessed and compared the content of consent forms for
            biobank research. The objective of this study was to perform a survey and content
            analysis of currently used consent forms in German biobanks.
         </p>
      </div>
      <div id="s1">
         <h2>MATERIALS AND METHODS</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">To improve the comprehensiveness, reliability, validity, and objectivity of our assessment
            of biobank specific consent forms, we first systematically developed an assessment
            matrix of potentially relevant issues that might be addressed in consent documents
            for biobank research. We then applied this assessment matrix to a sample of consent
            forms from German biobanks.
         </p>
         <div id="">
            <h3>DEVELOPMENT OF THE ASSESSMENT MATRIX</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">To identify issues that might be addressed in consent documents for biobank research,
               we referred to frequently cited policies, guidelines, and regulations dealing with
               general recommendations for consent procedures in biomedical research (mainly clinical
               studies) and/or biobank research. More specifically, we used nine prominent guidelines
               for biomedicine (
               <span ref-type="bibr" rid="B9">Council of Europe, 1997</span>), biomedical research with humans in general (
               <span ref-type="bibr" rid="B17">European Parliament and the Council of the European Union, 2001</span>; 
               <span ref-type="bibr" rid="B8">Council for International Organizations of Medical Sciences [CIOMS], 2002</span>; 
               <span ref-type="bibr" rid="B16">European Medicines Agency [EMEA], 2002</span>; 
               <span ref-type="bibr" rid="B10">Council of Europe, 2005</span>; 
               <span ref-type="bibr" rid="B38">World Medical Association [WMA], 2008</span>; 
               <span ref-type="bibr" rid="B37">US Department of Health and Human Services, 2009</span>), and biobank or biomaterial research in particular (
               <span ref-type="bibr" rid="B11">Council of Europe, 2006</span>; 
               <span ref-type="bibr" rid="B31">OECD, 2009</span>). For the national (German) context, we referred to a “commented checklist” of issues
               in patient information and consent for clinical studies with an annex for biobank
               research (
               <span ref-type="bibr" rid="B22">Harnischmacher et al., 2006</span>). The set of selected guideline is a purposive sample. Most of the chosen guidelines
               are, for instance, indicated as important legal and ethical frameworks in other sources
               such as the Oxford Textbook of Clinical Research Ethics (
               <span ref-type="bibr" rid="B7">Capron, 2008</span>; 
               <span ref-type="bibr" rid="B15">Emanuel et al., 2008</span>). We have discussed the selection of guidelines and the resulting construct validity
               of the matrix of consent issues internally and with experts from the fields of law
               and biobank research.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In all ten documents, one author (Irene Hirschberg) searched for text passages that
               explicitly or implicitly mentioned issues of potential relevance to the content of
               consent forms in biomedical research in general, and applicable to biobank research.
               Examples mentioned as necessary information for consent included “general procedures
               and safeguards used to protect privacy and confidentiality,” the “policy with respect
               to benefit sharing” and “information on the human biological material and data to
               be collected, their intended uses, storage, transfer and their disposal technique”
               (
               <span ref-type="bibr" rid="B31">OECD, 2009</span>). An example for a relevant but implicitly mentioned issue dealt with the removal
               of biological materials after death: “biological materials should not be removed from
               the body of a deceased person for research activities without appropriate consent
               or authorisation.” (
               <span ref-type="bibr" rid="B11">Council of Europe, 2006</span>) Other issues were mentioned only in relation to the research protocol, such as “incentives
               for subjects” (
               <span ref-type="bibr" rid="B38">World Medical Association [WMA], 2008</span>),” or came under the discussion of policy, but indicated as relevant to participants:
               “The HBGRD’s policy should also address the situation where participants become legally
               incapacitated or die. It is essential that the HBGRD provide information on their
               policy to the participant or the appropriate substitute decision-maker at the time
               of consenting.” (
               <span ref-type="bibr" rid="B31">OECD, 2009</span>) The results and any ambiguity were discussed with the other authors (Hannes Knüppel
               and Daniel Strech). We excluded generally important aspects of biomedical research
               that were mentioned in one or more guidelines but were not considered relevant to
               the content of consent forms in biobank research, e.g., “trial treatment and random
               assignment (
               <span ref-type="bibr" rid="B16">European Medicines Agency [EMEA], 2002</span>)” and “alternative procedures or courses of treatment” (
               <span ref-type="bibr" rid="B37">US Department of Health and Human Services, 2009</span>). We also excluded formal aspects such as “title of the document” or “date/signature”
               (
               <span ref-type="bibr" rid="B22">Harnischmacher et al., 2006</span>).
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">We compared the mentions of issues relevant to consent forms in biobank research in
               different guidelines, and developed categories for similar mentions of issues. During
               the development of these categories, we slightly adapted the items arising from the
               clinical study context to the biobank context. For instance, we revised the wording
               “duration of participation in trial/study” to “duration of participation or storage.”
               In some cases we performed a synthesis of issues, e.g., subsuming “money or material
               goods” (
               <span ref-type="bibr" rid="B8">Council for International Organizations of Medical Sciences [CIOMS], 2002</span>), “payment” and “expenses” (
               <span ref-type="bibr" rid="B16">European Medicines Agency [EMEA], 2002</span>), “additional costs” (
               <span ref-type="bibr" rid="B37">US Department of Health and Human Services, 2009</span>), “incentives” (
               <span ref-type="bibr" rid="B38">World Medical Association [WMA], 2008</span>), and “allowance” (
               <span ref-type="bibr" rid="B22">Harnischmacher et al., 2006</span>) under “Payment/allowance and additional costs.” We finally obtained 41 items grouped
               under four main headings (see Results and 
               <b>Table 
                  <span ref-type="table" rid="T1">1</span>
               </b>). Each of the 41 items derives from at least two guidance documents.
            </p>
            <div tagxxx="table-wrap">
               <div tagxxx="label">Table 1</div>
               <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
                  <p>Representation of 41 consent issues for biobank research in 30 German consent documents.</p>
               </caption>
               <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hsidesgroups55
                  <thead>
                     <tr>
                        <div tagxxx="th">Consent issues for biobank research</div>
                        <div tagxxx="th">Origin: mention in guidelines for the regulation of biomedical research (
                           <i>n</i> = 10)
                           <div tagxxx="hr"></div>
                        </div>
                        <div tagxxx="th">Application: mention in biobank-specific consent documents (
                           <i>n</i> = 30)
                           <div tagxxx="hr"></div>
                        </div>
                     </tr>
                     <tr>
                        <div tagxxx="th">Assessment items</div>
                        <div tagxxx="th">
                           <i>n</i>
                        </div>
                        <div tagxxx="th">%</div>
                        <div tagxxx="th">
                           <i>n</i>
                        </div>
                        <div tagxxx="th">%</div>
                     </tr>
                  </thead>
                  <div tagxxx="tbody">
                     <tr>
                        <td>topleft11
                           <b>(A) General information</b>
                        </td>
                     </tr>
                     <tr>
                        <td>topleft11Research explanation and purpose</td>
                        <td>topleft1110</td>
                        <td>topleft11100</td>
                        <td>topleft1128</td>
                        <td>topleft1193</td>
                     </tr>
                     <tr>
                        <td>topleft11Future development and changes</td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft119</td>
                        <td>topleft1130</td>
                     </tr>
                     <tr>
                        <td>topleft11Biobank design and structure</td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft1121</td>
                        <td>topleft1170</td>
                     </tr>
                     <tr>
                        <td>topleft11Funding and (conflict of) interests</td>
                        <td>topleft116</td>
                        <td>topleft1160</td>
                        <td>topleft116</td>
                        <td>topleft1120</td>
                     </tr>
                     <tr>
                        <td>topleft11Duration of participation or storage</td>
                        <td>topleft117</td>
                        <td>topleft1170</td>
                        <td>topleft1115</td>
                        <td>topleft1150</td>
                     </tr>
                     <tr>
                        <td>topleft11Biomaterial: types and quantity of specimen</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft1127</td>
                        <td>topleft1190</td>
                     </tr>
                     <tr>
                        <td>topleft11Data: type and quantity of data</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft1119</td>
                        <td>topleft1163</td>
                     </tr>
                     <tr>
                        <td>topleft11Description of collection procedures and additional tests</td>
                        <td>topleft118</td>
                        <td>topleft1180</td>
                        <td>topleft1126</td>
                        <td>topleft1187</td>
                     </tr>
                     <tr>
                        <td>topleft11Sample collection: further examination needed/follow up-points</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft1123</td>
                        <td>topleft1177</td>
                     </tr>
                     <tr>
                        <td>topleft11Rights/ownership of samples and data and their transfer</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft1117</td>
                        <td>topleft1157</td>
                     </tr>
                     <tr>
                        <td>topleft11Opinion or approval of ethical review board/committee</td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft1116</td>
                        <td>topleft1153</td>
                     </tr>
                     <tr>
                        <td>topleft11
                           <b>(B) Conditions of participation</b>
                        </td>
                     </tr>
                     <tr>
                        <td>topleft11Dimension of consent: scope, safeguards and conditions</td>
                        <td>topleft114</td>
                        <td>topleft1140</td>
                        <td>topleft1115</td>
                        <td>topleft1150</td>
                     </tr>
                     <tr>
                        <td>topleft11Free and voluntary participation</td>
                        <td>topleft1110</td>
                        <td>topleft11100</td>
                        <td>topleft1124</td>
                        <td>topleft1180</td>
                     </tr>
                     <tr>
                        <td>topleft11Right to withdraw or alter consent (without disadvantage)</td>
                        <td>topleft1110</td>
                        <td>topleft11100</td>
                        <td>topleft1129</td>
                        <td>topleft1197</td>
                     </tr>
                     <tr>
                        <td>topleft11Withdrawal: modalities and consequences regarding biomaterial and data</td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft1124</td>
                        <td>topleft1180</td>
                     </tr>
                     <tr>
                        <td>topleft11Decision on participation/withdrawal without affecting medical care or relationship
                           to physician
                        </td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft1115</td>
                        <td>topleft1150</td>
                     </tr>
                     <tr>
                        <td>topleft11Compensation and insurance cover</td>
                        <td>topleft117</td>
                        <td>topleft1170</td>
                        <td>topleft115</td>
                        <td>topleft1117</td>
                     </tr>
                     <tr>
                        <td>topleft11Options (partial consent)</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft1116</td>
                        <td>topleft1153</td>
                     </tr>
                     <tr>
                        <td>topleft11
                           <b>(C) Consequences of participation</b>
                        </td>
                     </tr>
                     <tr>
                        <td>topleft11Direct benefit for participant</td>
                        <td>topleft1110</td>
                        <td>topleft11100</td>
                        <td>topleft1115</td>
                        <td>topleft1150</td>
                     </tr>
                     <tr>
                        <td>topleft11Indirect benefit for subgroups or society</td>
                        <td>topleft1110</td>
                        <td>topleft11100</td>
                        <td>topleft1119</td>
                        <td>topleft1163</td>
                     </tr>
                     <tr>
                        <td>topleft11Risk</td>
                        <td>topleft1110</td>
                        <td>topleft11100</td>
                        <td>topleft1121</td>
                        <td>topleft1170</td>
                     </tr>
                     <tr>
                        <td>topleft11Payment/allowance or additional costs</td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft1110</td>
                        <td>topleft1133</td>
                     </tr>
                     <tr>
                        <td>topleft11Benefit-sharing</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft1118</td>
                        <td>topleft1160</td>
                     </tr>
                     <tr>
                        <td>topleft11Feedback on findings or incidental findings</td>
                        <td>topleft116</td>
                        <td>topleft1160</td>
                        <td>topleft1120</td>
                        <td>topleft1167</td>
                     </tr>
                     <tr>
                        <td>topleft11Publication of data only unlinked</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft1117</td>
                        <td>topleft1157</td>
                     </tr>
                     <tr>
                        <td>topleft11Re-contacting of participant: purpose and conditions </td>
                        <td>topleft114</td>
                        <td>topleft1140</td>
                        <td>topleft1118</td>
                        <td>topleft1160</td>
                     </tr>
                     <tr>
                        <td>topleft11Contact person/point</td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft1118</td>
                        <td>topleft1160</td>
                     </tr>
                     <tr>
                        <td>topleft11
                           <b>(D) Dealing with data and biomaterial</b>
                        </td>
                     </tr>
                     <tr>
                        <td>topleft11Confidentiality of records and data/extent and limits of confidentiality</td>
                        <td>topleft119</td>
                        <td>topleft1190</td>
                        <td>topleft1124</td>
                        <td>topleft1180</td>
                     </tr>
                     <tr>
                        <td>topleft11Privacy rights and procedures/safeguards, data processing, and identifiability of
                           data and samples
                        </td>
                        <td>topleft116</td>
                        <td>topleft1160</td>
                        <td>topleft1127</td>
                        <td>topleft1190</td>
                     </tr>
                     <tr>
                        <td>topleft11Use of health data and records and their purpose</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft1120</td>
                        <td>topleft1167</td>
                     </tr>
                     <tr>
                        <td>topleft11Storage of data and biomaterial</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft1120</td>
                        <td>topleft1167</td>
                     </tr>
                     <tr>
                        <td>topleft11Policy for genetic information/consent to genetic analyses</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft1112</td>
                        <td>topleft1140</td>
                     </tr>
                     <tr>
                        <td>topleft11Contact with or disclosure to participant’s physician</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft1119</td>
                        <td>topleft1163</td>
                     </tr>
                     <tr>
                        <td>topleft11Policy on use/disclosure to third parties for non-research purpose</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft117</td>
                        <td>topleft1123</td>
                     </tr>
                     <tr>
                        <td>topleft11Sharing data and material with other researchers/policy and process</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft1124</td>
                        <td>topleft1180</td>
                     </tr>
                     <tr>
                        <td>topleft11International cooperation/trans-border use</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft117</td>
                        <td>topleft1123</td>
                     </tr>
                     <tr>
                        <td>topleft11Commercialisation and collaboration with for-profit entities</td>
                        <td>topleft115</td>
                        <td>topleft1150</td>
                        <td>topleft1117</td>
                        <td>topleft1157</td>
                     </tr>
                     <tr>
                        <td>topleft11Right of access to personal data</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft115</td>
                        <td>topleft1117</td>
                     </tr>
                     <tr>
                        <td>topleft11Disposal or destruction of data and material</td>
                        <td>topleft113</td>
                        <td>topleft1130</td>
                        <td>topleft1121</td>
                        <td>topleft1170</td>
                     </tr>
                     <tr>
                        <td>topleft11Dealing with data and material after participants die or become incapacitated</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft110</td>
                        <td>topleft110</td>
                     </tr>
                     <tr>
                        <td>topleft11Removal of material after death</td>
                        <td>topleft112</td>
                        <td>topleft1120</td>
                        <td>topleft111</td>
                        <td>topleft113</td>
                     </tr>
                  </div>
               </table>
            </div>
         </div>
         <div id="">
            <h3>BIOBANK SURVEY AND ANALYSIS OF THE CONSENT DOCUMENTS</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">To get an overview of consent documents and templates currently used in biobank research
               in Germany, we considered all biobanks registered in the German Biobank Registry (“Deutsches
               Biobanken-Register,” 
               <div tagxxx="ext-link"></div>) in July 2012. We excluded six of the 108 registered biobanks because they were either
               doubly mentioned in the register or did not exist anymore (or their web site could
               not be accessed). Nine of the remaining 102 biobanks had consent forms publically
               available on their websites. We asked the heads of the other 93 biobanks via email
               to send us their consent documents. In this email we made clear that German biobanks
               will not be named individually in the dissemination of findings from our study. The
               response rate after repeated contact was 48% (44/90 biobanks, three mailing addresses
               were incorrect). Not all biobanks were willing to provide their consent document;
               some biobanks used a shared consent form, and two biobanks provided two documents
               for different purposes. At last, we were able to include 30 consent documents of 33
               biobanks in our analysis. If the biobanks provided additional participant information
               and a consent form, we included both documents in the analysis.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The representation of all 41 items in each of the 30 consent documents was assessed
               according to standards in thematic text analysis (
               <span ref-type="bibr" rid="B13">Dixon-Woods et al., 2005</span>). All researchers were experienced in thematic text analysis and research ethics.
               The consent forms were read in full by two authors (Irene Hirschberg and Hannes Knüppel)
               independently to identify and extract text passages corresponding to each of the 41
               consent issues for biobank research. For the purpose of this study the authors only
               rated whether the items were mentioned or not. For example, the authors did not evaluate
               in depth whether these items were sufficiently comprehensible. After the independent
               text extraction and rating the researchers compared their results. Discrepancies between
               the resulting spreadsheets were identified in 114 (9.3%) of all 1,230 ratings (41
               ratings for each of the 30 consent forms). These discrepancies were discussed and
               resolved with the third author (Daniel Strech).
            </p>
         </div>
      </div>
      <div id="">
         <h2>RESULTS</h2>
         <div id="">
            <h3>ASSESSMENT MATRIX</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Our assessment matrix comprises 41 items in four categories: (A) “General information”
               covering, e.g., explanation of the type of research and its purpose, (B) “Conditions
               of participation” including background on voluntary participation, consent conditions
               and scope, (C) “Consequences of participation” comprising items on, e.g., risks and
               benefits, and (D) “Dealing with data and biomaterial” encompassing items on, e.g.,
               data protection measures and cooperation with other parties. 
               <b>Table 
                  <span ref-type="table" rid="T1">1</span>
               </b> presents the 41 items of the assessment matrix for consent in biobank research, the
               number of guidance sets from which each item derived, and the extent to which the
               items were mentioned in the German biobank sample (see 
               <b>Table 
                  <span ref-type="table" rid="T1">1</span>
               </b>).
            </p>
         </div>
         <div id="">
            <h3>GERMAN CONSENT DOCUMENTS FOR BIOBANK RESEARCH</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Our sample comprised 30 consent documents from 33 German biobanks registered in the
               German Biobank Registry in July 2012. The sample includes different types of biobank
               with varying characteristics as type (population-wide or disease-specific biobank,
               or clinical study with sample collections), number of participants, organization and
               funding, and inclusion of healthy probands or patients (e.g., inclusion of all admitted
               patients). However, all registered biobanks are considered to perform biobank research.
               The German Biobank Registry is operated by the TMF (Technology, Methods, and Infrastructure
               for Networked Medical Research) and is funded by the German Federal Ministry of Education
               and Research.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Most of the biobanks had developed their own consent documents; one biobank just used
               a consent form for genetic diagnostic similar to a template of the German Society
               of Human Genetics. The consent documents (participant information and consent form)
               varied in several characteristics, e.g., in length of document (one to five pages),
               target group (patient, healthy participant, next kin, children, or parents), scope
               of consent, content, complexity and comprehensibility.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The coverage of the 41 items by the 30 consent documents was very variable. One item
               (“Right to withdraw or alter consent (without disadvantage)”) was addressed in 97%,
               another item (“Dealing with data and material after participants die or become incapacitated”)
               was not addressed by any consent form (see 
               <b>Table 
                  <span ref-type="table" rid="T1">1</span>
               </b>). Though for the interpretation of the results, it has to be considered that a few
               items – as “Removal of samples after death” – are not applicable to all biobanks.
               Nevertheless, in these cases the items were counted as “not mentioned”.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A large majority of the German consent documents referred to items as in section (A)
               such as e.g., “Research explanation and purpose” (93%) and “Biomaterial: types and
               quantity of specimen” (90%), to elementary conditions in (B) such as “Free and voluntary
               participation” (80%) or “Right to withdraw or alter consent (without disadvantage)”
               (97%) and to basic aspects in section (D) such as “Confidentiality of records and
               data/extent and limits of confidentiality” (80%) and “Privacy rights and procedures/safeguards,
               data processing, and identifiability of data and samples” (90%).
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Information on some controversially discussed or partly not foreseeable items was
               given less frequently e.g., for general information (section (A)) such as “Future
               development and changes” (30%) or information on “Rights/Ownership of samples and
               data and their transfer” (57%). Also some points regarding the conditions of participation
               (section (B)) were considered by just half of the documents, e.g., “Decision on participation/withdrawal
               without affecting medical care or relationship to physician” (50%) or “Options/partial
               consent” (53%). Of the items regarding the consequences of participation (section
               (C)), the most mentioned was “Risk” (70%) and the least-mentioned “Payment/Allowance
               or additional costs” (33%). The mentioning of risks ranged from: no any mentioned
               risks at all over minimal risks for the sample/blood-taking procedure to a very detailed
               description of the risks using genetic data. (The latter refer to for example the
               knowledge as such and the related psychological burdens for the donor or family members,
               implication on re-identifiability of “anonymized” data, and potential implications
               on health insurance and employment).
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Some items of presumably high importance for biobank research (in section (D) “Dealing
               with data and biomaterial”) were mentioned infrequently, e.g., “International Cooperation/trans-border
               use” (23%), “Right of access to personal data” (17%) or “Policy on use/disclosure
               to third parties for non-research purpose” (23%).
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The number of items found also varied widely among the 30 consent documents (see 
               <b>Table 
                  <span ref-type="table" rid="T2">2</span>
               </b>), from a minimum of 9 (22%) to a maximum of 36 (88%). The median of items addressed
               across all 30 consent forms was 25.5 items (62%).
            </p>
            <div tagxxx="table-wrap">
               <div tagxxx="label">Table 2</div>
               <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
                  <p>Distribution of assessment items (
                     <i>n</i> = 41, divided into five ranges) for consent content in biobank research, found in
                     consent documents of a German biobank sample (
                     <i>n</i> = 30)
                  </p>
               </caption>
               <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hsidesgroups55
                  <thead>
                     <tr>
                        <div tagxxx="th">Assessment items for consent in biobank research
                           <div tagxxx="hr"></div>
                        </div>
                        <div tagxxx="th">Mention in German biobank consent documents
                           <div tagxxx="hr"></div>
                        </div>
                     </tr>
                     <tr>
                        <div tagxxx="th">Range</div>
                        <div tagxxx="th">n</div>
                        <div tagxxx="th">%</div>
                     </tr>
                  </thead>
                  <div tagxxx="tbody">
                     <tr>
                        <td>topleft1133–41 (approx. 80–100%)</td>
                        <td>topleft113</td>
                        <td>topleft1110</td>
                     </tr>
                     <tr>
                        <td>topleft1125–32 (approx. 60–80%)</td>
                        <td>topleft1114</td>
                        <td>topleft1147</td>
                     </tr>
                     <tr>
                        <td>topleft1117–24 (approx. 40–60%)</td>
                        <td>topleft116</td>
                        <td>topleft1120</td>
                     </tr>
                     <tr>
                        <td>topleft119–16 (approx. 20–40%)</td>
                        <td>topleft117</td>
                        <td>topleft1123</td>
                     </tr>
                     <tr>
                        <td>topleft110–8 (approx. 0–20%)</td>
                        <td>topleft110</td>
                        <td>topleft110</td>
                     </tr>
                  </div>
               </table>
            </div>
         </div>
      </div>
      <div id="">
         <h2>DISCUSSION AND CONCLUSION</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">This study illustrates that consent documents from 30 German biobanks differ widely
            in the range of issues that they address. Out of 41 potentially relevant issues (systematically
            identified in leading guidelines on consent in biomedical research) only three consent
            forms (10%) address more than 80% while another seven consent forms (23%) address
            less than 40%.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">One should bear in mind that the consideration of more items does not facilitate consent
            or increase its validity 
            <i>per se</i>. Nevertheless, one should have reasonable motives to minimize the extent of content
            and leave out relevant items.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">With respect to the existing heterogeneity and different types of biobanks, it has
            to be considered that not all of the mentioned items must be applicable or equally
            relevant to each biobank. Nevertheless, core criteria for consent in biobank research
            and could be harmonized on an at least abstract level. Such abstract templates could
            then be adapted to the individual national or local context. In the German sample
            it is remarkable that items with a presumably high significance for biobank research
            in general (
            <span ref-type="bibr" rid="B6">Cambon-Thomsen et al., 2007</span>; 
            <span ref-type="bibr" rid="B21">Hansson, 2009</span>; 
            <span ref-type="bibr" rid="B31">OECD, 2009</span>; 
            <span ref-type="bibr" rid="B5">Budimir et al., 2011</span>) were mentioned in less than 25% of all consent forms, e.g., “International Cooperation/trans-border
            use,” “Right of access to personal data” and “Policy on use/disclosure to third parties
            for non-research purpose.” The low coverage of such issues in consent forms may be
            partly because new developments in data protection law and research agendas are not
            foreseeable in detail. But it may be also because of a still limited awareness of
            legal, ethical, and practical challenges in biobank research and the need for their
            transparent communication to potential participants (
            <span ref-type="bibr" rid="B19">Gottweis and Kaye, 2012</span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Concerning the complexity of information, empirical studies need to assess which potentially
            relevant content issues for consent forms in biobank research can be condensed or
            simplified without minimizing the validity of the consent and the tissue donors’ understanding
            of biobank research. For a first step in this direction see Beskow (
            <span ref-type="bibr" rid="B3">Beskow et al., 2010</span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Our study has the following limitations: as a demand of further research it would
            be worthwhile to expand or modify the guidance-based assessment matrix for consent
            in biobank research in the following way: (1) to define a set of core criteria or
            balance the assessment items regarding their importance or relevance, (2) to outline
            explaining dimensions for these items, and (3) to further analyze which aspects are
            not covered sufficiently by the matrix respectively by the included guidances (e.g.,
            diagnostic/therapeutic misconception). Such conceptual and empirical research would
            provide the basis for a deeper evaluation of existing consent documents and for the
            development of new consent documents. Within our explorative study of German biobank
            consent documents we only considered whether a potentially relevant content issue
            was mentioned in a consent form at all. We evaluated neither the accuracy of the explanation
            of this issue nor its quality, comprehensibility, or readability. Furthermore, we
            did not assess criteria for supportive decision-making (e.g., IPDAS-criteria 
            <span ref-type="bibr" rid="B26">IPDAS, 2005</span>; 
            <span ref-type="bibr" rid="B14">Elwyn et al., 2006</span>). These assessment criteria are certainly important for the development and evaluation
            of valid consent procedures as shown e.g., by (
            <span ref-type="bibr" rid="B3">Beskow et al., 2010</span>; 
            <span ref-type="bibr" rid="B4">Brehaut et al., 2012</span>). Another limitation arises from the fact that we could only include 32% of consent
            forms from the full sample of 102 biobanks registered in the German Biobank Registry.
            However, our sample of 30 consent forms included all leading German biobanks with
            relatively high quality standards (including all six biobanks that are part of the
            National Biobank Initiative funded by the German Federal Ministry of Education and
            Research, BMBF). We suppose that the inclusion of further consent forms would not
            have changed the overall picture of the strong heterogeneity of consent forms for
            biobank research. Moreover, we would even expect a wider variation in content issues.
            Other investigations have reached similar results and support the finding that consent
            material in general, or in biomedical and biobank research in particular, needs improvement
            (
            <span ref-type="bibr" rid="B32">Padhy et al., 2011</span>; 
            <span ref-type="bibr" rid="B33">Pawlikowski et al., 2011</span>; 
            <span ref-type="bibr" rid="B4">Brehaut et al., 2012</span>; 
            <span ref-type="bibr" rid="B28">Mandava et al., 2012</span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taking into account the widely shared vision of national and international networking
            of biobanks and increased activities in data and sample sharing, our findings demonstrate
            the need of improvement and harmonization of consent procedures in the field of biobank
            research. Furthermore, such improvements are important to fulfil the demand of responsible
            biobank governance and to maintain public trust in biobank research (
            <span ref-type="bibr" rid="B19">Gottweis and Kaye, 2012</span>). This does also include transparent communication on consent procedures. As described
            in the methods section only nine consent templates (8.8%) of the 102 initially identified
            biobanks were available publically on the biobanks’ web sites. Furthermore, even after
            repeated contact and the guarantee to anonymize the results for our assessment of
            consent forms only 32% of registered German biobanks were willing to provide their
            present consent form. Beside the need to improve and harmonize consent procedures,
            increased transparency of such basic information should become a major aim of German
            biobanks, to demonstrate appropriate standards of governance.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">When it comes to future improvement and harmonization of consent forms, public attitudes
            and expert opinion in relevant fields such as law, ethics, medicine, natural science
            etc. should be sought to define core criteria for consent. It may also help to overcome
            the lack of awareness of potentially relevant consent items and to address them in
            an appropriate way.
         </p>
      </div>
      <div id="">
         <h2>CONCLUSION</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Our findings serve as a starting point to reflect upon the spectrum of relevant consent
            issues in biobank research. The present study supports the systematic and transparent
            development of a “best practice” model of consent for biobank research. The findings
            show that at least the majority of consent documents in German biobanks should be
            improved and harmonized to better support an informed and balanced choice by potential
            donors and to facilitate research cooperation and networking. Further steps of such
            a best practice model would include the development of a best practice consent template
            (considering content, adherence to quality and language criteria) followed by a discussion
            and review of the template with other stakeholders (e.g., researchers, research ethics
            committees, potential biobank participants, patients’ representatives, and ethicists).
            Especially for a best practice model for consent forms, the understanding and validity
            of the text should be tested empirically (
            <span ref-type="bibr" rid="B36">Sugarman et al., 2005</span>; 
            <span ref-type="bibr" rid="B18">Flory et al., 2008</span>). Finally, its use should be accompanied by continuous evaluation.
         </p>
      </div>
      <div id="">
         <h2>Conflict of Interest Statement</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The authors declare that the research was conducted in the absence of any commercial
            or financial relationships that could be construed as a potential conflict of interest.
         </p>
      </div>
      <div tagxxx="back">
         <div tag="ref-list">
            <ul>
               <div tagxxx="title">REFERENCES</div>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Asslaber</span>
                           <span tagx="given-names">M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Zatloukal</span>
                           <span tagx="given-names">K.</span>
                        </div>
                     </div> (
                     <span tagx="year">2007</span>). 
                     <span tagx="article-title">Biobanks: transnational, European and global networks.</span>
                     <span tagx="source">
                        <i>Brief. Funct. Genomic Proteomic.</i>
                     </span>
                     <span tagx="volume">6</span>
                     <span tagx="fpage">193</span>–
                     <span tagx="lpage">201</span>
                     <div tagxxx="pub-id">10.1093/bfgp/elm023</div>
                     <div tagxxx="pub-id">17916592</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Ayuso</span>
                           <span tagx="given-names">C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Millan</span>
                           <span tagx="given-names">J. M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancheno</span>
                           <span tagx="given-names">M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dal-Re</span>
                           <span tagx="given-names">R.</span>
                        </div>
                     </div> (
                     <span tagx="year">2013</span>). 
                     <span tagx="article-title">Informed consent for whole-genome sequencing studies in the clinical setting.</span>
                     <span tagx="source">Proposed recommendations on essential content and process.
                        <i> Eur. J. Hum. Genet.</i>
                     </span>
                     <span tagx="volume">21</span>
                     <span tagx="fpage">1054</span>–
                     <span tagx="lpage">1059</span>
                     <div tagxxx="pub-id">10.1038/ejhg.2012.297</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Beskow</span>
                           <span tagx="given-names">L. M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Friedman</span>
                           <span tagx="given-names">J. Y.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Hardy</span>
                           <span tagx="given-names">N. C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lin</span>
                           <span tagx="given-names">L.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Weinfurt</span>
                           <span tagx="given-names">K. P.</span>
                        </div>
                     </div> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">Developing a simplified consent form for biobanking.</span>
                     <span tagx="source">
                        <i>PLoS ONE </i>5:e13302.
                     </span>
                     <div tagxxx="pub-id">10.1371/journal.pone.0013302</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Brehaut</span>
                           <span tagx="given-names">J. C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Carroll</span>
                           <span tagx="given-names">K.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Elwyn</span>
                           <span tagx="given-names">G.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Saginur</span>
                           <span tagx="given-names">R.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kimmelman</span>
                           <span tagx="given-names">J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Shojania</span>
                           <span tagx="given-names">K.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2012</span>). 
                     <span tagx="article-title">Informed consent documents do not encourage good-quality decision making.</span>
                     <span tagx="source">
                        <i>J. Clin. Epidemiol.</i>
                     </span>
                     <span tagx="volume">65</span>
                     <span tagx="fpage">708</span>–
                     <span tagx="lpage">724</span>
                     <div tagxxx="pub-id">10.1016/j.jclinepi.2012.01.004</div>
                     <div tagxxx="pub-id">22537428</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Budimir</span>
                           <span tagx="given-names">D.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Polasek</span>
                           <span tagx="given-names">O.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Marusic</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kolcic</span>
                           <span tagx="given-names">I.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Zemunik</span>
                           <span tagx="given-names">T.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Boraska</span>
                           <span tagx="given-names">V.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2011</span>). 
                     <span tagx="article-title">Ethical aspects of human biobanks: a systematic review.</span>
                     <span tagx="source">
                        <i>Croat. Med. J</i>
                     </span>
                     <span tagx="volume">52</span>
                     <span tagx="fpage">262</span>–
                     <span tagx="lpage">279</span>
                     <div tagxxx="pub-id">10.3325/cmj.2011.52.262</div>
                     <div tagxxx="pub-id">21674823</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Cambon-Thomsen</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rial-Sebbag</span>
                           <span tagx="given-names">E.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Knoppers</span>
                           <span tagx="given-names">B. M.</span>
                        </div>
                     </div> (
                     <span tagx="year">2007</span>). 
                     <span tagx="article-title">Trends in ethical and legal frameworks for the use of human biobanks.</span>
                     <span tagx="source">
                        <i>Eur. Respir. J.</i>
                     </span>
                     <span tagx="volume">30</span>
                     <span tagx="fpage">373</span>–
                     <span tagx="lpage">382</span>
                     <div tagxxx="pub-id">10.1183/09031936.00165006</div>
                     <div tagxxx="pub-id">17666560</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Capron</span>
                           <span tagx="given-names">A. M.</span>
                        </div>
                     </div> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">“Legal and regulatory standards of informed consent in research,” in</span>
                     <span tagx="source">
                        <i>Oxford Textbook of Clinical Research Ethics</i>
                     </span>
                     <div tagxxx="role">eds</div>
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Emanuel</span>
                           <span tagx="given-names">E. J. </span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Grady</span>
                           <span tagx="given-names">C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Crouch</span>
                           <span tagx="given-names">R. A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lie</span>
                           <span tagx="given-names">R. K.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Miller</span>
                           <span tagx="given-names">F. G.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Wendler</span>
                           <span tagx="given-names">D.</span>
                        </div>
                     </div> (
                     <div tagxxx="publisher-loc">Oxford</div>: 
                     <div tagxxx="publisher-name">Oxford University Press</div>) 
                     <span tagx="fpage">613</span>–
                     <span tagx="lpage">632</span>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">Council for International Organizations of Medical Sciences [CIOMS].</div> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">
                        <i>International Ethical Guidelines for Biomedical Research Involving Human Subjects</i>.
                     </span>
                     <div tagxxx="publisher-loc">Geneva</div>: 
                     <div tagxxx="publisher-name">CIOMS.</div> Available at: 
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">Council of Europe.</div> (
                     <span tagx="year">1997</span>). 
                     <span tagx="article-title">
                        <i>Convention for the Protection of Human Rights and Dignity of the Human Being with
                           Regard to the Application of Biology and Medicine: convention on Human Rights and
                           Biomedicine
                        </i>.
                     </span>
                     <div tagxxx="publisher-loc">Strasbourg</div>: 
                     <div tagxxx="publisher-name">Council of Europe.</div> Available at: 
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">Council of Europe.</div> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">
                        <i>Additional Protocol to the Convention on Human Rights and Biomedicine Concerning Biomedical
                           Research
                        </i>.
                     </span>
                     <div tagxxx="publisher-loc">Strasbourg</div>: 
                     <div tagxxx="publisher-name">Council of Europe.</div> Available at: 
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">Council of Europe.</div> (
                     <span tagx="year">2006</span>). 
                     <span tagx="source">
                        <i>Recommendation Rec (2006)4 of the Committee of Ministers to member states on research
                           on biological materials of human origin.
                        </i>
                     </span>
                     <div tagxxx="publisher-loc">Strasbourg</div>: 
                     <div tagxxx="publisher-name">Council of Europe.</div> Available at:
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">Deutscher Ethikrat.</div> (
                     <span tagx="year">2011</span>). 
                     <span tagx="source">
                        <i>Humanbiobanken für die Forschung.</i>
                     </span>
                     <div tagxxx="publisher-loc">Berlin</div>: 
                     <div tagxxx="publisher-name">Deutscher Ethikrat</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Dixon-Woods</span>
                           <span tagx="given-names">M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Agarwal</span>
                           <span tagx="given-names">S.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Jones</span>
                           <span tagx="given-names">D.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Young</span>
                           <span tagx="given-names">B.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sutton</span>
                           <span tagx="given-names">A.</span>
                        </div>
                     </div> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">Synthesising qualitative and quantitative evidence: a review of possible methods.</span>
                     <span tagx="source">
                        <i>J. Health Serv. Res. Policy</i>
                     </span>
                     <span tagx="volume">10</span>
                     <span tagx="fpage">45</span>–
                     <span tagx="lpage">53</span>
                     <div tagxxx="pub-id">10.1258/1355819052801804</div>
                     <div tagxxx="pub-id">15667704</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Elwyn</span>
                           <span tagx="given-names">G.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">O’connor</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Stacey</span>
                           <span tagx="given-names">D.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Volk</span>
                           <span tagx="given-names">R.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Edwards</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Coulter</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2006</span>). 
                     <span tagx="article-title">Developing a quality criteria framework for patient decision aids: online international
                        Delphi consensus process.
                     </span>
                     <span tagx="source">
                        <i>BMJ</i>
                     </span>
                     <span tagx="volume">333</span>
                     <div tagxxx="issue">417</div>
                     <div tagxxx="pub-id">10.1136/bmj.38926.629329.AE</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Emanuel</span>
                           <span tagx="given-names">E. J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Grady</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Crouch</span>
                           <span tagx="given-names">R. A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lie</span>
                           <span tagx="given-names">R. K.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Miller</span>
                           <span tagx="given-names">F. G.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Wendler</span>
                           <span tagx="given-names">D.</span>
                        </div>
                     </div> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">
                        <i>Oxford Textbook of Clinical Research Ethics</i>.
                     </span>
                     <div tagxxx="publisher-loc">Oxford</div>: 
                     <div tagxxx="publisher-name">Oxford University Press</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">European Medicines Agency [EMEA].</div> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">
                        <i>CPMP/ICH/135/95 Guideline for Good Clinical Practice, ICH Topic E 6 (R1)</i>.
                     </span>
                     <div tagxxx="publisher-loc">London</div>: 
                     <div tagxxx="publisher-name">European Medicines Agency</div> Available at: 
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">European Parliament and the Council of the European Union.</div> (
                     <span tagx="year">2001</span>). 
                     <span tagx="article-title">
                        <i>Directive 2001/20/EC on the Approximation of the Laws, Regulations and Administrative
                           Provisions of the Member States Relating to the Implementation of Good Clinical Practice
                           in the Conduct of Clinical Trials on Me-dicinal Products for Human Use
                        </i>, Luxembourg.
                     </span>
                     <div tagxxx="publisher-loc">Available at</div>: 
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Flory</span>
                           <span tagx="given-names">J. H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Wendler.</span>
                           <span tagx="given-names">D.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Emanuel</span>
                           <span tagx="given-names">E.</span>
                        </div>
                     </div> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">“Empirical issues in informed consent for research,” in</span>
                     <span tagx="source">
                        <i>Oxford Textbook of Clinical Research Ethics</i>
                     </span>
                     <div tagxxx="role">eds</div>
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Emanuel</span>
                           <span tagx="given-names">E. J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Grady</span>
                           <span tagx="given-names">C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Crouch</span>
                           <span tagx="given-names">R. A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lie</span>
                           <span tagx="given-names">R. K.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Miller</span>
                           <span tagx="given-names">F. G.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Wendler</span>
                           <span tagx="given-names">D.</span>
                        </div>
                     </div> (
                     <div tagxxx="publisher-loc">Oxford</div>: 
                     <div tagxxx="publisher-name">Oxford University Press)</div>
                     <span tagx="fpage">645</span>–
                     <span tagx="lpage">660</span>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Gottweis</span>
                           <span tagx="given-names">H.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kaye</span>
                           <span tagx="given-names">J.</span>
                        </div>
                     </div> (
                     <span tagx="year">2012</span>). 
                     <span tagx="source">
                        <i>Biobanks for Europe: A Challenge for Governance</i>.
                     </span>
                     <div tagxxx="publisher-loc">Report of the Expert Group on Dealing with Ethical and Regulatory Challenges of International
                        Biobank Research. Luxembourg
                     </div>: 
                     <div tagxxx="publisher-name">European Commission</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Greely</span>
                           <span tagx="given-names">H. T.</span>
                        </div>
                     </div> (
                     <span tagx="year">2007</span>). 
                     <span tagx="article-title">The uneasy ethical and legal underpinnings of large-scale genomic biobanks.</span>
                     <span tagx="source">
                        <i>Annu. Rev. Genomics Hum. Genet.</i>
                     </span>
                     <span tagx="volume">8</span>
                     <span tagx="fpage">343</span>–
                     <span tagx="lpage">364</span>
                     <div tagxxx="pub-id">10.1146/annurev.genom.7.080505.115721</div>
                     <div tagxxx="pub-id">17550341</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hansson</span>
                           <span tagx="given-names">M. G.</span>
                        </div>
                     </div> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">Ethics and biobanks.</span>
                     <span tagx="source">
                        <i>Br. J. Cancer</i>
                     </span>
                     <span tagx="volume">100</span>
                     <span tagx="fpage">8</span>–
                     <span tagx="lpage">12</span>
                     <div tagxxx="pub-id">10.1038/sj.bjc.6604795</div>
                     <div tagxxx="pub-id">19034276</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Harnischmacher</span>
                           <span tagx="given-names">U.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ihle</span>
                           <span tagx="given-names">P.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Berger</span>
                           <span tagx="given-names">B.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Goebel</span>
                           <span tagx="given-names">J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Scheller</span>
                           <span tagx="given-names">J.</span>
                        </div>
                     </div> (
                     <span tagx="year">2006</span>). 
                     <span tagx="article-title">
                        <i>Checkliste und Leitfaden zur Patienteneinwilligung</i>.
                     </span>
                     <div tagxxx="publisher-loc">Grundlagen und Anleitung für die Klinische Forschung. Berlin</div>: 
                     <div tagxxx="publisher-name">Medizinisch Wissenschaftliche Verlagsgesellschaft</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hirtzlin</span>
                           <span tagx="given-names">I.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dubreuil</span>
                           <span tagx="given-names">C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Preaubert</span>
                           <span tagx="given-names">N.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Duchier</span>
                           <span tagx="given-names">J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Jansen</span>
                           <span tagx="given-names">B.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Simon</span>
                           <span tagx="given-names">J.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">An empirical survey on biobanking of human genetic material and data in six EU countries.</span>
                     <span tagx="source">
                        <i>Eur. J. Hum. Genet.</i>
                     </span>
                     <span tagx="volume">11</span>
                     <span tagx="fpage">475</span>–
                     <span tagx="lpage">488</span>
                     <div tagxxx="pub-id">10.1038/sj.ejhg.5201007</div>
                     <div tagxxx="pub-id">12774042</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hoeyer</span>
                           <span tagx="given-names">K.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Olofsson</span>
                           <span tagx="given-names">B. O.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mjorndal</span>
                           <span tagx="given-names">T.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lynoe</span>
                           <span tagx="given-names">N.</span>
                        </div>
                     </div> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">The ethics of research using biobanks: reason to question the importance attributed
                        to informed consent.
                     </span>
                     <span tagx="source">
                        <i>Arch. Intern. Med.</i>
                     </span>
                     <span tagx="volume">165</span>
                     <span tagx="fpage">97</span>–
                     <span tagx="lpage">100</span>
                     <div tagxxx="pub-id">10.1001/archinte.165.1.97</div>
                     <div tagxxx="pub-id">15642883</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hüppe</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dziubek</span>
                           <span tagx="given-names">K.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Raspe</span>
                           <span tagx="given-names">H.</span>
                        </div>
                     </div> (
                     <span tagx="year">2013</span>). 
                     <span tagx="article-title">Zum Verbesserungspotenzial schriftlicher Aufklärungsmaterialien zu (bio)medizinischen
                        Forschungsvorhaben – Empirische Analyse von Antragsunterlagen einer Forschungsethikkommission.
                     </span>
                     <span tagx="source">
                        <i>Ethik Med. </i>
                     </span>
                     <div tagxxx="pub-id">10.1007/s00481-013-0257-5</div>
                     <div tagxxx="comment">[Epub ahead of print]</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">IPDAS.</div> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">“Criteria for judging the quality of patient decision aids. Checklist,” in</span>
                     <span tagx="source">
                        <i>International Patient Decision Aids Standards (IPDAS) Collaboration</i>
                     </span>. Available at: 
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Jefford</span>
                           <span tagx="given-names">M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Moore</span>
                           <span tagx="given-names">R.</span>
                        </div>
                     </div> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">Improvement of informed consent and the quality of consent documents.</span>
                     <span tagx="source">
                        <i>Lancet Oncol.</i>
                     </span>
                     <span tagx="volume">9</span>
                     <span tagx="fpage">485</span>–
                     <span tagx="lpage">493</span>
                     <div tagxxx="pub-id">10.1016/S1470-2045(08)70128-1</div>
                     <div tagxxx="pub-id">18452859</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mandava</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pace</span>
                           <span tagx="given-names">C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Campbell</span>
                           <span tagx="given-names">B.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Emanuel</span>
                           <span tagx="given-names">E.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Grady</span>
                           <span tagx="given-names">C.</span>
                        </div>
                     </div> (
                     <span tagx="year">2012</span>). 
                     <span tagx="article-title">The quality of informed consent: mapping the landscape.</span>
                     <span tagx="source">A review of empirical data from developing and developed countries.
                        <i> J. Med. Ethics</i>
                     </span>
                     <span tagx="volume">38</span>
                     <span tagx="fpage">356</span>–
                     <span tagx="lpage">365</span>
                     <div tagxxx="pub-id">10.1136/medethics-2011-100178</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mascalzoni</span>
                           <span tagx="given-names">D.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Janssens</span>
                           <span tagx="given-names">A. C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Stewart</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pramstaller</span>
                           <span tagx="given-names">P.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gyllensten</span>
                           <span tagx="given-names">U.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rudan</span>
                           <span tagx="given-names">I.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">Comparison of participant information and informed consent forms of five European
                        studies in genetic isolated populations.
                     </span>
                     <span tagx="source">
                        <i>Eur. J. Hum. Genet.</i>
                     </span>
                     <span tagx="volume">18</span>
                     <span tagx="fpage">296</span>–
                     <span tagx="lpage">302</span>
                     <div tagxxx="pub-id">10.1038/ejhg.2009.155</div>
                     <div tagxxx="pub-id">19826451</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">McGuire</span>
                           <span tagx="given-names">A. L.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Beskow</span>
                           <span tagx="given-names">L. M.</span>
                        </div>
                     </div> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">Informed consent in genomics and genetic research.</span>
                     <span tagx="source">
                        <i>Annu. Rev. Genomics Hum. Genet.</i>
                     </span>
                     <span tagx="volume">11</span>
                     <span tagx="fpage">361</span>–
                     <span tagx="lpage">381</span>
                     <div tagxxx="pub-id">10.1146/annurev-genom-082509-141711</div>
                     <div tagxxx="pub-id">20477535</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">OECD.</div> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">
                        <i>Guidelines on Human Biobanks and Genetic Research Databases</i>.
                     </span>
                     <div tagxxx="publisher-loc">Paris</div>: 
                     <div tagxxx="publisher-name">Organisation for Economic Co-Operation and Development (OECD)</div> Avaialble at: 
                     <div tagxxx="ext-link"></div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Padhy</span>
                           <span tagx="given-names">B. M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gupta</span>
                           <span tagx="given-names">P.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gupta</span>
                           <span tagx="given-names">Y. K.</span>
                        </div>
                     </div> (
                     <span tagx="year">2011</span>). 
                     <span tagx="article-title">Analysis of the compliance of informed consent documents with good clinical practice
                        guideline.
                     </span>
                     <span tagx="source">
                        <i>Contemp. Clin. Trials</i>
                     </span>
                     <span tagx="volume">32</span>
                     <span tagx="fpage">662</span>–
                     <span tagx="lpage">666</span>
                     <div tagxxx="pub-id">10.1016/j.cct.2011.05.016</div>
                     <div tagxxx="pub-id">21664297</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Pawlikowski</span>
                           <span tagx="given-names">J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sak</span>
                           <span tagx="given-names">J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Marczewski</span>
                           <span tagx="given-names">K.</span>
                        </div>
                     </div> (
                     <span tagx="year">2011</span>). 
                     <span tagx="article-title">Biobank research and ethics: the problem of informed consent in Polish biobanks.</span>
                     <span tagx="source">
                        <i>Arch. Med. Sci.</i>
                     </span>
                     <span tagx="volume">7</span>
                     <span tagx="fpage">896</span>–
                     <span tagx="lpage">901</span>
                     <div tagxxx="pub-id">10.5114/aoms.2011.25568</div>
                     <div tagxxx="pub-id">22291838</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Porteri</span>
                           <span tagx="given-names">C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Borry</span>
                           <span tagx="given-names">P.</span>
                        </div>
                     </div> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">A proposal for a model of informed consent for the collection, storage and use of
                        biological materials for research purposes.
                     </span>
                     <span tagx="source">
                        <i>Patient Educ. Couns.</i>
                     </span>
                     <span tagx="volume">71</span>
                     <span tagx="fpage">136</span>–
                     <span tagx="lpage">142</span>
                     <div tagxxx="pub-id">10.1016/j.pec.2007.12.003</div>
                     <div tagxxx="pub-id">18243633</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Salvaterra</span>
                           <span tagx="given-names">E.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lecchi</span>
                           <span tagx="given-names">L.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Giovanelli</span>
                           <span tagx="given-names">S.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Butti</span>
                           <span tagx="given-names">B.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bardella</span>
                           <span tagx="given-names">M. T.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bertazzi</span>
                           <span tagx="given-names">P. A.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">Banking together.</span>
                     <span tagx="source">A unified model of informed consent for biobanking
                        <i>.</i>
                        <i>EMBO Rep.</i>
                     </span>
                     <span tagx="volume">9</span>
                     <span tagx="fpage">307</span>–
                     <span tagx="lpage">313</span>
                     <div tagxxx="pub-id">10.1038/embor.2008.41</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Sugarman</span>
                           <span tagx="given-names">J.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lavori</span>
                           <span tagx="given-names">P. W.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Boeger</span>
                           <span tagx="given-names">M.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Cain</span>
                           <span tagx="given-names">C.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Edsond</span>
                           <span tagx="given-names">R.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Morrison</span>
                           <span tagx="given-names">V.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">Evaluating the quality of informed consent.</span>
                     <span tagx="source">
                        <i>Clin. Trials</i>
                     </span>
                     <span tagx="volume">2</span>
                     <span tagx="fpage">34</span>–
                     <span tagx="lpage">41</span>
                     <div tagxxx="pub-id">10.1191/1740774505cn066oa</div>
                     <div tagxxx="pub-id">16279577</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">US Department of Health and Human Services.</div> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">“Code of federal regulations,” in</span>
                     <span tagx="source">
                        <i>Title 45 Part 46. Protection of Human Subjects</i>
                     </span>. 
                     <div tagxxx="publisher-loc">Washington, DC</div>: 
                     <div tagxxx="publisher-name">U.S. Department of Health and Human Services</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="collab">World Medical Association [WMA].</div> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">
                        <i>Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects</i>.
                     </span>
                     <div tagxxx="publisher-loc">Seoul</div>: 
                     <div tagxxx="publisher-name">World Medical Association</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="mixed-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Zika</span>
                           <span tagx="given-names">E.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Paci</span>
                           <span tagx="given-names">D.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Schulte in Den Bäumen</span>
                           <span tagx="given-names">T.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Braun</span>
                           <span tagx="given-names">A.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sylvie</span>
                           <span tagx="given-names">R.-D.</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mylène</span>
                           <span tagx="given-names">D.</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">Biobanks in Europe: Prospects for Harmonisation and Networking.</span>
                     <div tagxxx="publisher-loc">EU-Report. Luxembourg</div>: 
                     <div tagxxx="publisher-name">Institute for Prospective Technological Studies</div>
                  </div>
               </li>
            </ul>
         </div>
      </div>
   </div>
</html>